Light at Night Exposure and Breast Cancer Risk: A Matched Case-Control Study in England

2018 ◽  
Vol 2017 (1) ◽  
pp. 851
Author(s):  
Susan Hodgson ◽  
Anna Freni Sterrantino ◽  
Alianore Descours ◽  
Amanda Cross ◽  
Adi McCrea ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jiayi Zhang ◽  
Baihui Tao ◽  
Yiran Chong ◽  
Shuang Ma ◽  
Gang Wu ◽  
...  

Abstract In vivo and vitro evidence indicates that ornithine and its related metabolic products play a role in tumor development. Whether ornithine is associated with breast cancer in humans is still unclear. We examined the association between circulating ornithine levels and breast cancer in females. This 1:1 age-matched case–control study identified 735 female breast cancer cases and 735 female controls without breast cancer. All cases had a pathological test to ascertain a breast cancer diagnosis. The controls were ascertained using pathologic testing, clinical examinations, and/or other tests. Fasting blood samples were used to measure ornithine levels. The average age for cases and controls were 49.6 years (standard deviation [SD] 8.7 years) and 48.9 years (SD 8.7 years), respectively. Each SD increase in ornithine levels was associated with a 12% reduction of breast cancer risk (adjusted odds ratio [OR] 0.88; 95% confidence interval [CI] 0.79–0.97). The association between ornithine and breast cancer did not differ by pathological stages of diagnosis or tumor grades (all P for trend > 0.1). We observed no effect measure modification by molecular subtypes (P for interaction = 0.889). In conclusion, higher ornithine levels were associated with lower breast cancer risk in females.


2010 ◽  
Vol 21 (12) ◽  
pp. 2281-2285 ◽  
Author(s):  
Qian Li ◽  
Tongzhang Zheng ◽  
Theodore R. Holford ◽  
Peter Boyle ◽  
Yawei Zhang ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Mariem Hajji-Louati ◽  
Emilie Cordina-Duverger ◽  
Nasser Laouali ◽  
Francesca-Romana Mancini ◽  
Pascal Guénel

AbstractDietary regimens promoting inflammatory conditions have been implicated in breast cancer development, but studies on the association between pro-inflammatory diet and breast cancer risk have reported inconsistent results. We investigated the association between the inflammatory potential of diet and breast cancer risk in a case–control study in France including 872 breast cancer cases and 966 population controls. All women completed a food frequency questionnaire that was used to compute a Dietary Inflammatory Index (DII) based on the inflammatory weight of 33 dietary components. The DII ranged from a median of − 3.22 in the lowest quartile (anti-inflammatory) to + 2.96 in the highest quartile (pro-inflammatory). The odds ratio contrasting quartile 4 to quartile 1 was 1.31 (95% CI 1.00, 1.73; p-trend = 0.02). Slightly higher odds ratios were observed in post-menopausal women, particularly those with body mass index > 25 kg/m2 (odds ratio 1.62; 95% CI 0.92, 2.83; p-trend = 0.02), and among ever smokers (odds ratio 1.71; 95% CI 1.11, 2.65; p-trend 0.01). The analyses by breast cancer subtype showed that the DII was associated with breast tumors that expressed either the estrogen (ER) or progesterone (PR) hormone receptors or the Human Epidermal Growth Factor Receptor-2 (HER2), but no association was seen for the triple negative breast tumor subtype. Our results add further evidence that a pro-inflammatory diet is associated with breast cancer risk with possible effect variation according to tumor subtype.


2011 ◽  
Vol 48 (10) ◽  
pp. 698-702 ◽  
Author(s):  
R. L. Milne ◽  
J. Lorenzo-Bermejo ◽  
B. Burwinkel ◽  
N. Malats ◽  
J. I. Arias ◽  
...  

2008 ◽  
Vol 14 (2) ◽  
pp. 131-135 ◽  
Author(s):  
Lívia Kipikašová ◽  
Tomáš Wolaschka ◽  
Peter Bohuš ◽  
Helena Baumohlová ◽  
Juraj Bober ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document